Stock Events

Stock Events

Resverlogix 

$0.08
12
-$0-4.88% Today

Statistics

Day High
0.07
Day Low
0.07
52W High
0.21
52W Low
0.02
Volume
10,000
Avg. Volume
7,931
Mkt Cap
21.84M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

31MarExpected
Q2 2024
Q3 2024
Q3 2024
Q1 2025
Q2 2025
Q3 2025
Next
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-15.27MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow RVXCF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
AMGEN
AMGN
Mkt Cap160.66B
Amgen develops similar cardiovascular treatments, competing in the same therapeutic areas as Resverlogix.
Regeneron Pharmaceuticals
REGN
Mkt Cap68.5B
Regeneron Pharmaceuticals competes in the cardiovascular and metabolic disease space, offering alternatives to Resverlogix's therapies.
Novartis
NVS
Mkt Cap237.61B
Novartis offers a range of cardiovascular drugs, directly competing with Resverlogix's pipeline.
Merck
MRK
Mkt Cap214.76B
Merck & Co. has a strong presence in the cardiovascular treatment market, making it a direct competitor.
Pfizer
PFE
Mkt Cap140.15B
Pfizer develops and markets drugs for cardiovascular diseases, competing with Resverlogix's products.
Astrazeneca
AZN
Mkt Cap256.58B
AstraZeneca has a portfolio of cardiovascular drugs, posing competition to Resverlogix.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol Myers Squibb offers cardiovascular therapies, directly competing with Resverlogix's drug development efforts.
Sanofi
SNY
Mkt Cap124.45B
Sanofi has a focus on cardiovascular diseases, making it a competitor in the same market as Resverlogix.
Gilead Sciences
GILD
Mkt Cap148.78B
Gilead Sciences competes in the cardiovascular space with its range of treatments.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie, through its acquisition of Allergan, has expanded its portfolio into cardiovascular diseases, competing with Resverlogix.

About

Resverlogix Corp., a late-stage clinical biotechnology company, develops therapeutics for patients with chronic illnesses. The company's lead drug is apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor for patients with cardiovascular disease, chronic kidney disease, type 2 diabetes mellitus, low high-density lipoprotein cholesterol, recent acute coronary syndrome, and post COVID-19 conditions. It has a partnership with Eversana Life Science Services, LLC to support the commercialization of apabetalone for COVID-19 in the United States and Canada; developing cardiovascular and pulmonary arterial hypertension indications; and Medison Pharma Ltd. The company is headquartered in Calgary, Canada.
Show more...
CEO
Mr. Donald J. McCaffrey
Employees
19
Country
CA
ISIN
CA76128M1086

Listings

OTC Link
US
RVXCF
TO
CA
RVX.TO
LSE
GB
0VF9.LSE
F
DE
RFS.F

0 Comments

Share your thoughts

FAQ

What is Resverlogix stock price today?▼
The current price of RVXCF is $0.08 USD — it has decreased by -4.88% in the past 24 hours. Watch Resverlogix stock price performance more closely on the chart.
What is Resverlogix stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Resverlogix stocks are traded under the ticker RVXCF.
Is Resverlogix stock price growing?▼
RVXCF stock has fallen by -4.88% compared to the previous week, the month change is a -15.44% fall, over the last year Resverlogix has showed a +153.67% increase.
What is Resverlogix market cap?▼
Today Resverlogix has the market capitalization of 21.84M
What is Resverlogix revenue for the last year?▼
Resverlogix revenue for the last year amounts to 0 USD.
What is Resverlogix net income for the last year?▼
RVXCF net income for the last year is -15.27M USD.
How many employees does Resverlogix have?▼
As of April 02, 2026, the company has 19 employees.
In which sector is Resverlogix located?▼
Resverlogix operates in the Health Care sector.
When did Resverlogix complete a stock split?▼
Resverlogix has not had any recent stock splits.
Where is Resverlogix headquartered?▼
Resverlogix is headquartered in Calgary, CA.